TAKP34:BVMF
Takeda Pharmaceutical Co Ltd BDR
R$125.64
0.00%
(0.00) 1D
Nov 18, 11:20:15 AM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TAKP34...
Mkt. cap
71.06B
Avg. vol.
25.00
Volume
0.00
52-wk high
R$125.76
52-wk low
R$75.60
Shares outstanding
1.60B
No. of employees
47K
Mkt. cap
71.06B
Avg. vol.
25.00
Volume
0.00
52-wk high
R$125.76
52-wk low
R$75.60
Shares outstanding
1.60B
No. of employees
47K
News stories
From web sources and news partners
The Motley Fool
·
1 hour ago
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
TradingKey
·
11 hours ago
S&P 500 Falls Below 200-Day Moving Average: Buy-the-Dip Opportunity or Bear Market Warning?
Beinsure
·
15 hours ago
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
StoneX
·
2 days ago
S&P 500, Nasdaq 100 Drive into Correction Territory
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the largest pharmaceutical company in Japan, third largest such company in Asia behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd BDR
CEOChristophe Weber | Christophe Weber
Employees47K
FoundedJun 12, 1781
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitetakeda.com